Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Dermatoses”

806 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 806 results

Not applicableUnknownNCT04275206
What this trial is testing

The Anti-inflammatory Effects of Harkány Medicinal Water

Who this might be right for
Rheumatoid ArthritisPsoriasis
University of Pecs 350
Not applicableUnknownNCT03432455
What this trial is testing

Incidence and Prevalence of Juvenile Dermatomyositis

Who this might be right for
Juvenile Dermatomyositis
University Hospital, Strasbourg, France 22
Not applicableStudy completedNCT05971992
What this trial is testing

INulin-type Fructans-induced Gut Microbiota Modulation Impact on GUT-SKIN Axis Parameters in Psoriasis

Who this might be right for
Psoriasis
Polish Academy of Sciences 56
Not applicableStudy completedNCT00530387
What this trial is testing

Multi-Centre European Photopatch Test Study

Who this might be right for
Dermatitis, Photocontact
NHS Tayside 1,000
Not applicableUnknownNCT04215458
What this trial is testing

Microbiota in Skin and Mucosa of Patients With Inflammatory Skin Diseases

Who this might be right for
Fungal InfectionInflammatory Skin DiseaseYeast Infection Skin
Zealand University Hospital 700
Testing effectiveness (Phase 2)Active Not RecruitingNCT02971748
What this trial is testing

Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy

Who this might be right for
Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Breast Inflammatory Carcinoma+2 more
M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT00295893
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 121
Not applicableUnknownNCT01038258
What this trial is testing

Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer Therapy

Who this might be right for
Invasive Ductal CarcinomaLobular Breast CarcinomaInflammatory Breast Carcinoma
Auxilio Mutuo Cancer Center 80
Large-scale testing (Phase 3)Study completedNCT01165008
What this trial is testing

Anakinra in Myositis

Who this might be right for
PolymyositisDermatomyositisInclusion Body Myositis
Karolinska Institutet
Testing effectiveness (Phase 2)Study completedNCT00066443
What this trial is testing

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 93
Not applicableStudy completedNCT04435925
What this trial is testing

Inflammatory Effect Comparison Between Fentanyl and Remifentanil in Mastectomy Under General Anesthesia

Who this might be right for
Breast DiseaseAnesthesiaInflammatory Response
Udayana University 48
Not applicableApproved For MarketingNCT05906706
What this trial is testing

Compassionate Use of Dupilumab for Adult Patients With Bullous Pemphigoid

Who this might be right for
Bullous Pemphigoid
Regeneron Pharmaceuticals
Not applicableLooking for participantsNCT06573723
What this trial is testing

Institutional Registry of Rare Diseases

Who this might be right for
Rare DiseasesAmyloidosisSarcoidosis+23 more
Hospital Italiano de Buenos Aires 380
Not applicableAvailableNCT04159597
What this trial is testing

Expanded Access to Upadacitinib

Who this might be right for
Crohn DiseaseUlcerative ColitisIdiopathic Arthritis (Including sJIA, pJIA, or JPsA)+1 more
AbbVie
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Testing effectiveness (Phase 2)Study completedNCT02199418
What this trial is testing

Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Ductal Breast Cancer+1 more
RenJi Hospital 132
Not applicableStudy completedNCT03779360
What this trial is testing

Intradermal LPS and Antibiotics

Who this might be right for
Inflammation; Skin
Centre for Human Drug Research, Netherlands 32
Not applicableStudy completedNCT00344071
What this trial is testing

Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia

Who this might be right for
Inflammatory Breast Cancer
National Cancer Institute (NCI) 250
Not applicableUnknownNCT06026020
What this trial is testing

Pathogenesis of Intestinal Behcet's Syndrome

Who this might be right for
Behcet's Syndrome, Intestinal Type
Peking Union Medical College Hospital 80
Early research (Phase 1)Enrolling By InvitationNCT07038447
What this trial is testing

KITE-363 in Participants With Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisSystemic Sclerosis+1 more
Kite, A Gilead Company 52
Load More Results